Trademarkia Logo

Canada

C$
COSTAR
WITHDRAWN BY OWNER

on 5 Jun 2023

Last Applicant/ Owned by

INSTIL BIO INC.

5949 Sherry LaneSuite 820Dallas, TX 75225

US

Serial Number

2194734 filed on 28th Jun 2022

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

800 rue du Square Victoria, bureau 3500Montréal,

QUEBEC

CA

H4Z1E9

COSTAR

Trademark usage description

cells for medical or clinical use; cells featuring digested tumor tissue and increased lymphocytes for medical or clinical use; biological preparation Read More

Classification Information


Class [005]
Cells for medical or clinical use; cells featuring digested tumor tissue and increased lymphocytes for medical or clinical use; biological preparations for the treatment of cancer and cellular disorders; reagents for medical use; drug delivery agents consisting of compounds that facilitate the preservation and delivery of a wide range of pharmaceuticals


Classification kind code

11

Class [010]
Medical specimen collection devices in the nature of bags and vials for the collection of biological tissue


Classification kind code

11

Class [040]
Custom manufacture of biological preparations, pharmaceutical preparations and cell therapy preparations


Classification kind code

11

Class [041]
Providing non-downloadable publications in the nature of articles, newsletters and brochures in the fields of cancer treatment and cell therapies; educational services, namely, conducting programs in the field of cancer treatment and cell therapies; educational services, namely, arranging and conducting classes, seminars and workshops in the fields of cancer treatment and cell therapies


Classification kind code

11

Mark Details


Serial Number

2194734

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 5
on 5th Jun 2023
Withdrawn by Owner
Submitted for opposition 287
on 21st Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 28th Jun 2022
Filed
Submitted for opposition 1
on 28th Jun 2022
Created
Submitted for opposition 31
on 28th Jun 2022
Formalized